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Introduction
The global horse industry is a multibillion-dollar global
concern. In the United States alone, the total economic
impact of the horse market, including racing, showing,
and recreation, was $102 billion in 2005, providing jobs
and products for breeding, training, and maintenance
(American Horse Council, 2005). However, because of
stringent breeding practices, many horse breeds have lost
genetic diversity, accumulated genetic mutations
(Petersen et al., 2013a, 2013b), and are afflicted by
genetic diseases (Finno, Spier, & Valberg, 2009; see
Table 1). Indigenous horse populations of East and
Southeast Asia (E/SE Asia; native, landrace, feral, and
wild; see Table 2) are genetically diverse. This includes
the only surviving wild population, the Przewalski’s
Horse (Lau et al., 2008; Figure 1). As such, they are a
potentially valuable resource for the global commercial
horse industry.
The Convention on Biological Diversity
(CBD)—“whose entry into force in 1993 contributed to
… establishing state sovereignty over biological and
genetic resources” (Vezzani, 2010, p. 678)—seeks to
conserve genetic resources (GRs) via an access- and ben-
efit-sharing (ABS) regime that envisions a systematic,
equitable, and workable balance between conservation
and use of GRs, including commercialization of prod-
ucts flowing from GRs. ABS should ideally facilitate
developed countries’ access to developing countries’
GRs, including fair compensation with monetary and
non-monetary benefits, thereby encouraging conserva-
tion (ten Kate & Laird, 1999). However, few E/SE Asian
countries, albeit parties to the CBD, have implemented
ABS measures, largely due to insufficient infrastructure
and lack of financial and human resources (Vivas-
Eugui, 2012).
While most GRs bioprospected from developing
countries have been from microorganisms and plants,
biotechnological advances now enable similar applied
utilization of animal GRs for research and development
of commercial applications (Gollin & Evenson, 2003;
ten Kate & Laird, 1999). The fundamental principles of
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plant GRs are applicable to animals. Development of
research and data are needed, however, to facilitate and
manage value in animal GRs (Gollin & Evenson, 2003).
Over the past decade, this concept has been reiterated:
“a critical component of agricultural biodiversity
is knowledge, including … scientific knowledge.
This aspect of … livestock biodiversity has not
been raised, most likely because there is little
applied work on the topic. Economics concepts
could be applied to investigate the value of infor-
mation about genetic resources and their diver-
sity” (Drucker, Smale, & Zambrano, 2005, p.
59).
To examine the concept of animal GR utilization pursu-
ant to the goals of the CBD, an ideal model system that
exemplifies and illustrates conservation, commercial
value, and informational assets is the horse.
We propose here an ABS system for coordinated uti-
lization and conservation of horse GRs from E/SE Asia,
a concept that can be extended to other animal GRs.
This ABS system includes building human resource and
institutional capacity (e.g., competent national authori-
ties [CNAs]) that catalog eco-geographical inventories
of horse GRs. CNAs can also monitor, manage, market,
and direct equitable value chains from horse to genetic
information to commercial products, and certify revenue
flow back to support conservation. An important aspect
of the proposed management system is consistent main-
tenance and tracking of proprietary rights to the genetic
information that the horse embodies. As such, this con-
servation scheme considers the horse as a repository of
proprietary information that imparts value and promotes
Table 1. Genetic diseases of the horse.
Genetic disease Breeds affected Gene name Inheritance pattern Population affected Population of carriers
HYPP Quarter horse SCN4A Semi-dominant 4% 56%
HERDA Quarter horse PPIB Recessive Unknown Cutting lineages 28%
GBED Quarter horse GBE1 Recessive Causes foal death 8.30%
American paint horse 7.10%
LWFS American paint horse EDNRB Semi-dominant Causes foal death Tobiano 94%
Quarter horse Other paint stock 21%
SCID Arabian PRKDC Recessive 0.18% 8.40%
JEB Belgians LAMC2 Recessive Causes foal death 17-27%
Other draft breeds
CSBB Appaloosas TRMP1 Recessive
PSSM Quarter horse GYS1 Recessive Unknown 6%
Belgians 36%
Sources: Finno et al. (2009); McCue et al. (2012); Horse Genome Project (2011)
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conservation, as distinguished from conservation para-
digms motivated by humane sentimentality and altru-
ism, e.g., giant pandas in China.
The Horse
There are approximately 500 breeds of domestic horses.
Selection and concentration of desired traits in horses
fulfill specific requirements: work, sport, or companion-
ship (Petersen et al., 2013a, 2013b). These can easily be
visualized in breeds such as the Friesian, whose size and
strength allowed knights in heavy armor to be carried
easily but also contained the fine bone structure required
for speed; this is contrasted with the Shetland Pony,
whose small but hardy frame was required to pull carts
through mine tunnels (The Friesian Horse Society, n.d.;
Johnson & Johnson, 2008). Five thousand years of artifi-
cial selection has redefined, focused, and narrowed the
equine genome. To perfect and maintain the purity breed,
most breed associations restrict registry to only those
animals that meet requirements and prohibit admixture
from breeds outside their registry. Such selection pres-
sure has led to polarities of genetic diversity (McCue et
al., 2012).
As a whole, the global horse population retains
genetic diversity, but this varies depending upon geo-
graphic origin as well as how recent a new breed was
cleaved from its ancestors (Petersen et al., 2013a,
2013b). Within many breeds, centuries of heavy selec-
tion pressure has decreased genetic diversity (Petersen
et al., 2013a, 2013b). For example the Thoroughbred,
which descended from 30 horses (27 sires and 3 dams)
has lost 16.3% heterozygosity (McCue et al., 2012;
Thiruvenkadan, Kandasamy, & Panneerselvam, 2009).
Ironically, inbreeding, although exerting high selection
pressure for speed for over 300 years, has not yielded a
significant increase in overall speed (Thiruvenkadan et
al., 2009). However, heavy and relentless selection pres-
sure has affected many horse breeds’ ability to survive a
bottleneck event, decreased fertility, and attenuated via-
bility (Juras, Cothran, & Klimas, 2003).
Originally domesticated 5,000 to 6,000 years ago,
wild horse populations once roamed much of the Eur-
asian steppes (Petersen et al., 2013a, 2013b; Warmuth et
al., 2011). E/SE Asian indigenous horses are repositories
of valuable genetic diversity. Numerous traits have been
exploited to develop many of the world’s 500 unique
breeds. Founding horse populations contained a wealth
of genetic diversity. However, because of artificial
selection and loss of most of the wild populations, this
pool of diversity is disappearing (McCue et al., 2012),
with a concomitant loss of potential value to the global
horse industry. For example, surviving horse GRs include
the wild Przewalski’s Horse (Equus przewalskii; Figure
1), which has been conserved; there are more than 1,500
animals worldwide and 300 reintroduced into its natural
habitat, Mongolia (Lau et al., 2008). Despite its two
additional chromosomes, it is closely related enough to
the domestic horse (Equus caballus) to produce fertile
offspring. However, the extinct wild horse of Eurasia, the
Tarpan (the last Tarpan died in 1909), is a source of
genetic diversity that has been permanently lost (Jansen
et al., 2002).
The domestic horse falls into three genetically dis-
tinct breed categories—native, feral, and landrace
(Petersen et al., 2013a, 2013b). Native breeds are desig-
nated according to origination from a specific region
(e.g., the Yili, a relatively recent breed known for speed
and endurance, was developed in China in the early
1900s by crossing Russian stock with other Chinese
native breeds; Ling et al., 2010). Feral breeds can trace
their lineage to domestic horses that escaped or were
released; whereas propagated via natural selection, they
retain specific traits (Csurhes, Paroz, & Markula, 2009).
Little is known genetically about the native and feral
horses of E/SE Asia, possibly due to poor access to sam-
ples (Miller, 2009). The only known feral breed in E/SE
Asia is the Misaki Pony found in Japan, which origi-
nated from Chinese horses released in Japan almost
2,000 years ago (Obata, Takeda, & Oishi, 1994). Lan-
drace breeds have high genetic diversity as well as a
series of traits that enable them to survive varying con-
ditions (McCue et al., 2012). The Lampang Pony of
Thailand is a landrace breed that, despite being in an
Figure 1. Przewalski’s horse (Equus przewalskii, also 
known as Mongolian ass, Asian wild horse, Mongolian wild 
horse, and takhi) is the last remaining true wild horse.   
Several reintroduced herds survive in Mongolia.
Photograph courtesy of Geoff Simpson/NaturePictureLibrary.
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environment where communicable diseases abound,
suffers little infection. Genetic testing suggests Przewal-
ski’s Horse may be an ancestor of some landrace breeds
(Carleton, 2008).
Strict breed regulations through registration and
breed associations’ efforts to “breed true” have likely
decreased genetic diversity (McCue et al., 2012) and
increased population frequencies of detrimental alleles.
It has also contributed to genetic disease expression
(Bannasch, 2008; Barakat, 2013; Finno et al., 2009)
such as hyperkalemic periodic paralysis (HYPP), severe
combined immunodeficiency (SCID), lethal white foal
syndrome (LWFS), congenital stationary night blind-
ness (CSNB), junctional epidermolysis bullosa (JEB),
glycogen branching enzyme deficiency (GBED), hered-
itary equine regional dermal asthenia (HERDA), and
polysaccharide storage myopathy (PSSM).
Horses as a Genetic Resource
Due to the lower biological and physical requirements for
bioprospecting, sample collection, and subsequent pro-
cessing, most GR access and utilization has focused on
plants and microorganisms (Deke, 2001; Gollin & Even-
son, 2003). However, as with the pharmaceutical, botan-
icals, and agricultural industries, the potential
application of GR-derived biotechnology to the horse
industry is linked to the underlying value proposition
(e.g., see Kesling, 2013). This value proposition is
driven by advances in biotechnology that facilitate cost-
effective mining of the horse genome.
Genetic research on horse populations is ongoing
and increasing in sophistication—in Canada, the Native
Mountain, Moorland, and Nordic pony populations
(Juras et al., 2003), and in Italy and Brazil for equine
diversity (DeAssis et al., 2009; Stasio, Perrotta, Blasi, &
Lisa, 2008). Subsets of horse breeds have been geneti-
cally tested to determine diversity of the species and
within specific breeds (McCue et al., 2012), along with
genome-wide analysis of breeds (Petersen et al., 2013a,
2013b). Analysis of complex genomes has become eco-
nomically feasible (Service, 2006). The Horse Genome
Project has mapped the Thoroughbred genome and
identified specific genes (e.g., speed capability), thereby
providing a research tool for a multitude of ailments as
well as other applications that could directly influence
the horse market (e.g., cloning of polo ponies; Adelson,
2012; Horse Genome Project, 2011). The Horse
Genome Project has facilitated an equine single-nucle-
otide polymorphism genotyping array, which identifies
genes for health, performance traits, genetic diversity,
origins of the domestic horse, and equine evolutionary
patterns (McCue et al., 2012). There has been a corre-
sponding increase in genomic patents relating to
equines, e.g., identification of grey alleles (associated
with side effects including increased susceptibility to
skin cancer; US Patent No. 8278043) and screening for
CSNB, a congenital disease that is linked to the leopard
appaloosa coat pattern gene (US Patent App. No.
20130112152A1).
Indigenous E/SE Asian horse populations are a
likely unutilized source of GRs that could provide bene-
fits to the country of origin, researchers and the global
commercial horse industry. As the tools of genetic anal-
ysis and biotechnology advance, the feasibility of utiliz-
ing these untapped GRs increases, for example, cloning
and genetic modification of domesticated breeds (e.g.,
genetic engineering of Przewalski’s horse genes into
polo pony clones; Adelson, 2012). Hence, as horse
genome research advances, accessing, developing, and
commercializing GRs from indigenous horses could
become an economically viable enterprise with broad
and equitable benefits, but only if effectively managed
and regulated. Over a decade ago, Deke (2001) pre-
dicted such a convergence of factors, i.e., that
“the scarcity of genetic resources is rising as
demand for them increases due to current
advances in biotechnology, while at the same
time availability decreases as genetically diverse
organism become increasingly extinct. In this
circumstances, a linkage between commercial-
ization and the conservation of biodiversity as
proposed by the Convention of Biodiversity may
succeed … [that] commercialization of genetic
resources may … represent a means to create
incentives for withholding natural areas from
conversion” (pp. 24, 26).
The Convention on Biological Diversity
The CBD provides the policy and practical basis for
equitably balancing conservation and commercialization
of horse GRs. Article 15 of the CBD provides guidelines
to signatories on ABS of GRs, i.e., a system where host
countries facilitate appropriate access to GRs to other
actors and in return receive some benefit (Montreal
Ministry of Sustainable Development, Environment and
Parks, Centre for International Sustainable Develop-
ment Law, 2008; ten Kate & Laird, 1999). Ideally, ABS
operates as a quasi quid pro quo system, where the
developing, primarily tropical, mega-biodiversity coun-
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tries provide GRs to the developed countries which then
transform the GRs—via biotechnology and other techni-
cal inputs—into commercial products (Lesser, 2000);
this system should entail reciprocal protection of prop-
erty rights and equitable sharing of value derived from
GRs. However, in practice ABS has not been readily
implemented; developing countries face many chal-
lenges, such as weak government infrastructure, inade-
quate investment in capacity building, and lack of
awareness relating to GR value and management
(Thornstrom, 2007). Perhaps this is ironic, as this need
has been echoed and reechoed. Indeed, nearly two
decades ago, Lesser (1998, p. 196) noted that “[v]irtu-
ally all knowledgeable observers from inside and out-
side the CBD, governments, companies, and the NGO
community recognize the need for capacity building and
funding.”
Adopted in 2002 as a non-legally binding addition to
the CBD, the Bonn Guidelines on Access to Genetic
Resources and the Fair and Equitable Sharing of Bene-
fits Arising out of Their Utilization (Bonn Guidelines)
are intended to establish ABS goals and requirements,
encourage conservation, promote capacity building, and
bridge the gap between nations that provide and those
that bioprospect and utilize GRs (Thornstrom, 2007;
Tully, 2003). Three components are necessary for an
effective ABS system: prior informed consent (PIC),
mutually agreed terms (MATs), and a material transfer
agreement (MTA). PIC, the contract that articulates
what the research project entails, is signed by all stake-
holders (e.g., government agencies, owners of private
property, and indigenous people) and ensures that all
parties understand the scope of the agreement. MATs
ensure fair and equitable sharing of benefits (Thorn-
strom & Bjork, 2007), including provisions of user and
provider states, type and quantity of the GRs, limitations
on use, access by third parties, and what provisions or
benefits (monetary and non-monetary) might be shared
if there is valuable utilization or derivatization of the GRs
(Tully, 2003). MTAs include a definition of the material
to be transferred, why it is being transferred, restrictions
on how it can be used, cost of transport, start and termi-
nation dates, and mechanisms and procedures to address
any breach of the agreement (Thornstrom & Bjork,
2007). As a progression of the Bonn Guidelines, the
Nagoya Protocol on Access to Genetic Resources and
the Fair and Equitable Sharing of Benefits Arising from
their Utilization to the CBD (Nagoya Protocol) was cre-
ated and opened for signature in 2011; the Nagoya Proto-
col makes many of the provisions of the Bonn Guidelines
legally enforceable, i.e., beyond the aspirational charac-
ter of much of the CBD (Kamau, Fedder, & Winter,
2010; Oliva, 2011).
The CBD stresses capacity building as a priority for
ABS implementation. In this regard, the Bonn Guide-
lines encourage provider countries to create CNAs that
coordinate and manage ABS (Tully, 2003) in order to
incentivize conservation of GRs in a sustainable manner
by equitably facilitating commercial access. However,
for this to occur, developing countries must invest in
ABS capacity building. This will enable equal bargain-
ing power with reciprocal benefits proportional to GR
that are bioprospected and developed commercially. In
addition, countries that have such capacity will be better
positioned to identify and manage intellectual property
rights (IPRs), further enabling access to a greater share
of potential value and benefits (ten Kate & Laird, 2000).
CBD ABS Systemic Challenges
Although outlined in the CBD and elucidated in the
Bonn Guidelines (and legally strengthened in the
Nagoya Protocol on ABS), the chronically unresolved
issue for the CBD (and resultant intellectual property
[IP]) is coherent ABS capacity building towards suc-
cessful and sustainable simultaneous use and conserva-
tion of GRs (Oliva, 2011; Tully, 2003). Most countries
have not attempted to implement ABS obligations, and
where implementation appears to have been pursued,
actual operational efficacy is, at best, questionable
(Wynberg & Laird, 2009). Indeed, despite 193 party
states having ratified the CBD, only about 60 have any
form of ABS measures in place, and fewer have coher-
ent policy implementation (Vivas-Eugui, 2012). ABS
system implementation becomes even more critical
when considering potential downstream IPR (Tully,
2003); IPR might be either an impediment or incentive
to effective and equitable ABS depending on manage-
ment capacity and capability. Hence, a preoccupation
with litigation of IP related to GRs (e.g., via attempts to
invalidate patents that allegedly embody biopirated GRs
or other unsustainable GR “management practices,”
such as expensive legal actions to pursue biopirates)
should be balanced with a workable system that uses IP
management as a tool for lowering the transaction costs
of ABS. In other words, use IP as a means to facilitate
transfer, development, and commercialization in addi-
tion to being a mechanism for legal action. However, the
ABS system has been largely stymied by an “absence of
adequate national regulatory clarity and institutional
capacity” (Harvey & Gericke, 2011, p. 333), thus per-
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petuating onerous transaction costs leading to market
failure.
Since its signature by 150 government leaders at the
1992 Rio Earth Summit, steps to implement the CBD’s
ABS provisions via establishment of CNAs have been
overshadowed, indeed smothered, by two decades of
largely politicized, misinformed, dis-informed, and use-
less high-level policy symposia and summits that have
been filled with discussions, but with little tangible
capacity building. Forums have become platforms for
divisive issues, distracting attention from ABS imple-
mentation and instead fomenting confusion and
estrangement (Wynberg & Laird, 2009). As Lesser
(2000, p. 49) observed over a decade ago, “four Confer-
ences of the Parties of the CBD appear to have made lit-
tle progress, and frustration appears to be increasing.”
Perhaps this is a paradigm problem, so that the issue
needs to be recast. The esoteric policy dimension of pre-
vious discussions deflates when the CBD’s ABS provi-
sions are conceptualized as a process. The mundane
business of establishing a workable system remains, and
as with any system (e.g., plumbing, electrical, or trans-
portation) a series of hubs, conduits, and connections
need to be established in order to facilitate efficiency.
However, as it currently exists, the CBD ABS system
interfaces are riddled with gaps—science policy, knowl-
edge, knowledge systems, assessments, communication,
ownership, and capacity (Chabason & Van Den Hove,
2009).
In E/SE Asia, ABS implementation largely remains
a work in progress. Among the first countries to have
laws regarding biological resource access, the Philip-
pines stands out in the E/SE Asian region with an imple-
mented ABS system. MAT regulations are also quite
developed (e.g., the minimum terms of an agreement on
bioprospecting). Provisions include not only PIC but
also royalty payments (CBD, 2013b). Japan’s ABS mea-
sures are consistent with the CBD and Bonn Guidelines
(Ministry of Economy, Trade and Industry, Japan &
Japan Bioindustry Association, 2006). Aside from the
Philippines (and to a lesser extent, Singapore, Korea and
Japan), most countries of E/SE Asia are deficient as to
implementation of ABS capabilities. China, a signatory
to the CBD, has a rudimentary ABS system. Despite an
apparent plethora of ABS somewhat specific policies,
and related laws and regulations, there is little evidence
that any substantial implementation has occurred (CBD,
2013a; State Council of the People’s Republic of China,
2008). Preliminary CBD ABS measures in Malaysia,
Thailand, and Vietnam—albeit encouraging—illustrate
that there appears to be little effort to establish func-
tional ABS systems in this region, and implementation
is (at best) still nascent (Southeast Asia Regional Capac-
ity Building on Access and Benefit Sharing, n.d.).
Genetic Resources and the Value Chain
Strategic ABS systemization for GRs can overcome
market failure by establishing “a market for biological
diversity conservation that internalizes into a market
transaction all the costs of the impacts of biological
diversity destruction and decline” (Lawson, 2006, p.
138). As applied to this study, this suggests that assign-
ment of value, property rights, and eventual commer-
cialization of connected assets arising from horse GRs
creates incentives for conservation of indigenous horses
of E/SE Asia. The mechanism to facilitate this is the
establishment and management of a system of property
rights, clearly delineated, which extend from the tangi-
ble material of the horse to the final IP (e.g., invention)
derived from there. In this way, the richness of informa-
tion embodied in the horse, whether it is protein, nucleic
acid-based, or other, can be accessed, valued, and uti-
lized with compensatory benefits derived for all parties
along the value chain. Furthermore, the GR must be
conceptualized as both tangible material and the intangi-
ble information embedded therein. Hence, two forms of
property rights are applicable—tangible (chattel) and
intellectual (information). For example, tangible prop-
erty rights can be applied to chattel (e.g., to blood, tissue
samples, embryos); IP rights can be applied as trade
secrets (genetic information protected as proprietary
business information; Kowalski, 2007) or patented
inventions (e.g., use of the nucleotide sequence of a
gene).
However, GR utilization as raw material for
advanced innovation has been fraught with market fail-
ure (i.e., underutilization of GR as an asset due to an
inadequate system of property rights, institutional
capacity, human capital, and management). This, in
turn, leads to under or over valuation and destructive
depletion of GR: “the private cost of using the environ-
ment does not coincide with its social cost. This effec-
tively favors those uses that are non-sustainable from an
ecological point of view” (Deke, 2008, p. 2). For exam-
ple, the components of an ecosystem are consumed
instead of conserved due to an inability to assign value
and property rights, i.e., the case of a forest being clear
cut instead of sustainably harvested for pharmaceutical
compounds. In addition, this situation is frustratingly
exacerbated because the tools for collecting and assay-
ing GRs are increasingly sophisticated (genomics, pro-
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teomics, metabolomics; Fridman & Pichersky, 2005),
such that efficient and economical bioprospecting
becomes systematic. Since each species (e.g., horses) can
be viewed as a finite gene pool (a discrete library of
information), irreversible erosion and loss of this infor-
mation might occur even as the tools to access it become
more refined, thus creating a situation that is simultane-
ously urgent and ironic.
The market failure quandary can be addressed by
building integrated systems of property rights, which
promote stable markets, coherent management, and pre-
dictable transactions. As Deke (2008, p. 4) notes, “by
laying down a framework of property rights in biodi-
verse areas and the GRs hosted therein, the holder of the
rights can receive sufficient revenues to forgo alterna-
tive, biodiversity-degrading land use and maintain natu-
ral areas as biodiversity habitats,” e.g., the possible
slaughter and extinction of horses in E/SE Asia, as had
been the fate of the Tarpan a century ago. It is therefore
important to not, “underestimate the costs of extractive
(as opposed to sustainable) development. Great care
must be taken … because once a species is lost, it is
gone forever, and ‘useful’ products cannot be harvested
from an extinct species” (Gollin, 1993, p. 188).
What is needed is a balance of two institutional
frameworks—public-sector administered allocation and
private-sector market allocation of information embed-
ded in GRs. This can facilitate efficient and sustainable
GR resource access, benefit sharing, and eventual com-
mercialization, thus affording equitable allocation of
value and distribution of compensation coupled to sus-
tainable conservation. In sum, when the institutional
environment is defined, and the participants understand
how to operate in the system, conservation and preser-
vation of GRs and biodiversity can be enhanced, pro-
moted, and sustained (Deke, 2008).
The CBD aspires to establish a working framework
for sustainable conservation via a defined, regulated,
and enforced system of benefit sharing; however, to
achieve this, a clear chain of property rights manage-
ment—from access to final commercialization—is
sorely needed as the foundation to build this framework
into a dynamic system. Compensatory benefits for all
parties along the value chain will drive a systematic
cycle, balancing use and conservation of GRs. Market
demand, albeit crucial, is insufficient; an efficient sys-
tem of clearly defined property rights is also equally
important to facilitate a predictable, equitable, and bal-
anced sequence of transactions (Deke, 2008; Frisvold &
Day-Rubenstein, 2008). The major weak link in this
value chain is a persistent lack of institutional capacity
in developing countries, which prohibitively increases
transaction costs and stymies GR utilization and conser-
vation. This is due largely to “a lack of political will on
the part of the country hosting valuable biodiversity
endowments and/or lack of national governance and
institutional capacities” (Deke, 2008, pp. 27-28). Hence,
capacity building in institutional infrastructure and
human capital are key steps to create the connections
needed for engaging in a global system that maximizes
GR potential while simultaneously preserving it. For the
conservation of horse populations of E/SE Asia, such a
system would be of significant benefit to the horses, the
countries of the region, and the global horse industry.
What are the system components necessary to make this
happen?
Recommendations
Global livestock biodiversity, including horses, is in a
state of decline, with at least 28% of breeds extinct,
endangered, or rare since the outbreak of the First World
War (Roosen, Fadlaoui, & Bertaglia, 2005). As the
global horse industry can be measured in the billions of
dollars (American Horse Council, 2005), preservation of
the horse gene pool is not only a humanitarian but also a
serious economic concern. Conservation strategies will
need to be driven by financial factors in addition to
humane sentimentalities. Hence, although systems for
identification and cataloguing, valuation, assignment of
property rights, and subsequent management towards
commercialization of animal GR assets still appear to be
at a nascent stage (Deke, 2008), the rapid convergence
of three factors—(1) the monetary value of the global
horse industry (estimated in the billions of dollars), (2)
the rapidly evolving analytical tools of biotechnology,
and (3) the finite (and possibly precarious) state of the
world horse genetic inventory—indicate that practical
steps towards implementation of management systems
are not only important, but urgent.
What is needed is a strategic plan for ABS imple-
mentation, which will simultaneously conserve and uti-
lize horse GRs. In this respect, fundamental theoretical
guidance on how to proceed has been provided:
“Viewed as inputs to the innovation process,
genetic materials have the potential to become
genuine resources in the context of a sufficiently
rich set of complementary knowledge assets. The
effective functioning of a market in GRs depends
on these knowledge assets just as much as, if not
more than, it relies on a sound system of IP rights
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and a robust capital market. This suggests that
attempts to estimate the value of GRs should
focus attention on how researchers form and
update their beliefs. It also suggests that the insti-
tutions regulating bioprospecting, including sys-
tems of IP rights, should reward the provision of
helpful prior information, as well as the conserva-
tion of the base biological material” (Rausser &
Small, 2000, p. 196).
The challenge is the implementation of theory into
practice. How can capacity building in human capital,
institutional infrastructure, and global networks provide a
sustainable system for ABS that is efficient and equita-
ble? The tools of biotechnology (e.g., genomics, pro-
teomics, metabolomics [Fridman & Pichersky, 2005;
Gollin & Evenson, 2003]) permit greater targeted bio-
prospecting with refinement and precision that is yet to
be realized, further increasing marginal value to horse
GRs. When used in conjunction with other knowledge
sources (e.g., traditional, indigenous knowledge, and
animal husbandry information on horse populations),
the synergistic effect of combined information can fur-
ther enhance potential value, as per Rausser and Small’s
(2008) proposition. However, full utilization and sustain-
able conservation will depend on an integrated and stable
system in which clearly delineated, managed, and
enforced property rights are essential.
Developing countries, which comprise the bulk of
mega-biodiversity (Deke, 2008), need to prioritize stra-
tegic and focused capacity building so as to engage in
and profit from this system, moving away from being
passive bystanders complaining about biopiracy.
Although many countries have acceded to the CBD,
with ABS provisions apparently planned, the number of
countries actually implementing ABS is small. In many
cases, CBD ABS “implementation” is under the author-
ity of environment ministries functioning as bureau-
cratic gatekeepers, with a subsequent lack of promotion,
and even outright deterrence, of possible value-added
bioprospecting towards commercialization and conser-
vation of GRs. In addition, much of the bioprospecting
“pursuant” to the ABS provisions of the CBD in devel-
oping countries has been undertaken by foreign organi-
zations, with little proactive participation by the
bioprospected country itself. In order to connect to a
global innovation market where the information assets
of GRs can be licensed, the mega-biodiverse countries
must implement practical measures toward a more pro-
active strategy aimed at promoting sustainable develop-
ment of GRs (Artuso, 2002; Rausser & Small, 2000).
Developing countries, therefore, need to carefully con-
sider whether to practically implement the ABS provi-
sion of the CBD via establishment of CNAs that
actually manage GRs. In the case of the indigenous
horse populations of E/SE Asia, this would necessarily
include the countries of the region wherein horses (or
perhaps more precisely, the genetic information which
the horses embody) are domiciled, i.e., as the sovereign
GR and biodiversity of those countries.
What steps need to be taken? Five prescriptive rec-
ommendations include to
1. establish human resource and institutional capacity
(CNAs);
2. catalog eco-geographical inventories of horse GRs
throughout the E/SE Asia region;
3. market horse GR inventories via a web-based, glob-
ally networked resource;
4. monitor, track, manage, and direct equitable, leak-
proof proprietary value chains from horse to genetic
information to commercial products; and
5. ensure revenue flow back to support conservation.
1) CNAs that Manage Horse GRs
To effectuate the CBD ABS provisions, as per the Bonn
guidelines, practical and predictable procedures need to
be established in developing countries, including clearly
identifiable centralized CNAs that administer these pro-
cedures in a competent coherent, professional, and effi-
cient manner. In many cases this will require investment
in building human capital and institutional infrastructure
(e.g., staffing with professionals fully capable of under-
standing, negotiating, and granting access to GRs and
subsequent contracts governing use and benefits). Cru-
cially, the developing countries themselves must con-
tribute significantly to this process and not expect
international donors to lead the initiative (Juma, 1993).
Such CNAs with sufficient capacity, in turn, would
facilitate systematic and sensible regulation of ABS of
biodiversity and GRs (Thornstrom, 2007), with
enhanced abilities to acquire technology, access infor-
mation, and foster global networks (Gollin, 1993). Tem-
plate agreements regulating ABS might include, but are
not necessarily limited to, letters of intent, research per-
mits, PIC, MAT, MTAs, confidentiality agreements
(Laird & Wynberg, 2008; Thornstrom & Bjork, 2007),
as well as license agreements with provisions (e.g.,
options and grant-backs) that ensure revenue and/or
other compensatory value flows back to the sources of
the biodiversity and GRs.
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In order to coordinate horse inventory management
with ABS strategic implementation, national and
regional focal points for inventory management of horse
GRs could partner or consolidate with CNAs. This
arrangement could catalyze establishment and imple-
mentation of a sustainable conservation/utilization sys-
tem for horse GRs and “further develop [global]
information sharing and technical cooperation, training,
and research” (Food and Agriculture Organization of the
United Nations [FAO], 2007, p. 36). Longer-term goals
and benefits should also include specific priority areas
that enhance and build inventory and horse GR manage-
ment (e.g., technical development, technology transfer,
collaborative programs, and associated education,
capacity building, and information networks; FAO,
2007). The CNA, as a focal point for managing regional
and national horse GRs, will then be the base of opera-
tions for the recommendations below (i.e., implementa-
tion).
2) Eco-geographical Inventories
To increase efficiency of E/SE Asian horse GR inven-
tory management, eco-geographical mapping as a tool
to inventory horse populations needs to be a priority. A
comprehensive compilation of data—including climatic,
ecological, geographical with cross-indexing to pheno-
typic, and genotypic information as available (Parra-
Quijano, Iriondo, Torres, & Rosa, 2011)—eco-geo-
graphical mapping is particularly applicable to locally
adapted populations of organisms. Although it has been
done predominantly with plants (Parra-Quijano, Iriondo,
& Torres, 2012), it has also been successfully applied to
animal populations (e.g., guanaco [Lama guanicoe]) in
the Andean region of South America; González, Palma,
Zapata, & Marín, 2006). Compiled information can be
catalogued into a database and mined for efficient iden-
tification of horse GRs (e.g., disease resistance, bone
density, endurance, or heat tolerance). Eco-geographical
mapping therefore provides a priori information that
increases bioprospecting efficiency, facilitates decision-
making, and thereby lowers transaction costs. This is
consistent with general theoretical principles of efficient
inventory management and business-cost containment
(Burja & Burja, 2010). Furthermore, there is a strong
likelihood of geographical genetic migration and local
adaptation of E/SE Asian horse populations (with possi-
ble gene flow from wild to native populations; Ishida,
Oyunsuren, Mashima, Mukoyama, & Saitou, 1995;
Kavar & Dovč, 2008; Lippold, Matzke, Reissmann, &
Hofreiter, 2011; Warmuth et al., 2011). Mapping infor-
mation can be a tool to more precisely predict and then
identify potentially valuable horse GRs, with commer-
cial applications.
In addition, cataloging inventories of horse GR is
consistent with the pioneering theoretical work of Deke
(2008, p. 62) that a priori information can “reduce ex
ante uncertainty … knowledge of specific GRs [serving]
as an indicator of promising information.” In other
words, information confers value on the GR such that
conservation is incentivized over wholesale obliterative
exploitation—the so-called tragedy of the commons
(Gollin, 1993). Thus, information builds to incremen-
tally reduce uncertainly, decrease attendant risk, and
impart marginal value. This, in turn, facilitates greater
efficiency in bioprospecting and subsequent research,
development, and commercial application of GR-
derived innovation.
3) Market Horse GR Inventories via a Web-
based, Globally Networked Resource
Access to horse GRs and biodiversity data and informa-
tion should be promoted via a dedicated web-based mar-
keting portal. This concept has already been proposed,
i.e., the Global Biodiversity Information Facility, a “data
publishing framework as an environment conducive to
ensure free and open access to the world’s biodiversity
data” (Moritz et al., 2011, p. 1).
This is standard business operating practice, and the
worldwide web now creates a global market portal that
is ubiquitously accessible. The lack of such a market
portal is a major limitation in the ABS system for horse
GRs, which must overcome the following situation:
“It is also believed that the lack of knowledge as
to what genetic resources are available, and
which might be potentially useful, is a major lim-
itation to industry being able to access genetic
resources. Changing this situation to facilitate an
increased demand for wild germplasm will
require considerable effort from provider coun-
tries. Costa Rica, for example, has spent a lot of
resources in developing an inventory and taxon-
omy of its biodiversity and ‘filling its shop win-
dow’ for potential customers [users] and this,
believe some, is what other countries must do.
Companies have noted the importance of ‘greater
realism’ in terms of the potential opportunities of
what is available and interesting. ‘If you don’t
know what is available, and who has the rights to
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provide it, it simply won’t work’” (Laird & Wyn-
berg, 2008, quoting Dr. Steve Smith 2007, p. 17).
Laird and Wynberg (2008, p. 37) explain that market-
ing of GRs fits into an overall ABS, CNA-based compre-
hensive strategy: “Provider countries and institutions that
actively build and market their biodiversity knowledge
base and associated capacity, and enter into partnerships
that help them to do this, receive greater benefits from
their biodiversity, and support biodiversity conservation
through these activities.”
4) Manage and Direct Equitable, Leak-proof, 
Proprietary Value Chains from Horse to Genetic 
Information to Commercial Products
The CBD recognizes that countries retain sovereignty
(ownership), over GRs within their borders (Fidler,
2008). But in terms of property and proprietary rights,
what are GRs? As articulated by Vezzani (2010, p. 678),
“the CBD … defines genetic resources as genetic mate-
rials (namely ‘any material of plant, animal, microbial,
or other origin containing functional units of heredity’)
of actual or potential value. It is acknowledged that this
definition is broad enough to include viruses.” It is criti-
cal to note that the CBD does not articulate information;
rather its focus is on materials, that is, tangible property.
Although the GRs discussed in this article is horses, the
best example of the loss of GR information (information
“leaked” away), that was subsequently raw “material”
for patenting, is found on a remotely distal branch of the
tree of life—viruses.
Information “leakiness” has likely occurred with
influenza virus samples shared through vaccine devel-
opment networks (i.e., third-party use of viral genetic
sequence data to develop and patent influenza-related
vaccine inventions; Vezzani, 2010; World Intellectual
Property Organization, 2011). In 2007, Indonesia
decided to withhold access to pandemic influenza
(H5N1) viral isolates, because viral materials could
become subject matter for third-party patents, without
equitable sharing or affordable access to the patented
health-care innovations. As a possible solution, Indone-
sia sought implementation of MTAs on viral samples
(Irwin, 2010; Laird & Wynberg, 2008). However, MTAs
are legal instruments (contracts) that define terms for
the transfer of tangible biological materials. “MTAs are
bailments that transfer possession but not title: the party
who transfers the materials retains full ownership; the
party who receives the materials holds them in trust”
(Bennett, Streitz, & Gacel, 2007, p. 697). Hence, albeit
specifically articulated as key ABS legal instruments,
MTAs do not per se address intangible property (i.e.,
information [IP] embedded in a bailed material). This
needs to be addressed by another legal instrument (e.g.,
confidentiality or non-disclosure agreements, possibly
pursuant to trade secret law; Gollin, 1993; Jorda, 2007).
Hence, Indonesia’s ad hoc attempts to “manage”
access to and use of viral clades as materials, pursuant to
the CBD and implemented by MTAs, might have been
doomed from the start. Information leaks and third par-
ties can then access and use it for research, development,
invention, and patenting. This concept of GR informa-
tion leakage has also been lucidly addressed by other
respected authorities: “[T]he genomic content of sam-
ples should be covered in agreements … intellectual
property and other rights are much more difficult to
manage for data compared with physical entities such as
pieces of DNA or biological molecules” (Laird & Wyn-
berg, 2008, p. 30). Since all earthly creatures—both great
and small—contain genetic information, the same princi-
ples that are exemplified in the Indonesian case (Sedyan-
ingsih, Isfandari, Soendoro, & Supari, 2008) must
therefore motivate and stimulate investment by the
developing countries themselves, in coherent capacity
building for management of GRs from organism to com-
mercial product. The viral sample case can be applied to
the indigenous horse populations of E/SE Asia (i.e., con-
trolling information leakage from GR).
5) Monitor, Track, Ensure Revenue Flow Back 
to Support Conservation
Compliance and tracking of GRs is a two-way street.
Developed countries’ industries need certainty and con-
tinuity for ABS and subsequent product development.
Developing, source countries desire equitable sharing of
derived and future value of GRs (Laird & Wynberg,
2008). Weakness at this point in the system has led to
reluctance on the part of developed country industries to
bioprospect. From an intellectual standpoint, arms-length
contractual ABS arrangements with upfront collection
and downstream royalty revenue streams appear feasible.
In reality, public-private partnerships (PPPs), built on
both trust and contract, with value-added capacity-build-
ing investments (such as in-country screening) create
perhaps a better, grounded, sound, and sustainable
approach (Lesser & Krattiger, 2007).
PPPs are among the more coherently proposed and
likely most easy to implement means for long-term
monitoring, tracking, and overall compliance. As Laird
and Wynberg (2008) have highlighted, PPPs have been
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primarily employed for non-animal GR ABS arrange-
ments. Seven cases are illustrative:
1. AstraZeneca and Griffith University in Queensland,
Australia: Natural-product drug discovery partner-
ship involving collections of terrestrial and marine
biodiversity from Queensland; benefits accrued over
time, with capacity building, technology transfer,
information, and understanding for conservation
planning and management.
2. Kenya Wildlife Service, International Centre for
Insect Physiology and Ecology, and Novozymes and
Diversa (now Verenium): Collection of microorgan-
isms in protected areas; arrangements based on
microorganism sourcing and ABS in the industrial
biotechnology sector.
3. The Ethiopian Institute of Biodiversity Conserva-
tion, the Ethiopian Agricultural Research Organiza-
tion, and the Dutch-based company Health and
Performance Food International: The cereal crop tef
(Eragrostis tef), a staple and among Ethiopia’s most
significant crop species, has gluten-free grain of
interest to the food industry.
4. Ball Horticulture and the South African National
Biodiversity Institute (SANBI): Select South Afri-
can plants of horticultural interest for Ball; commer-
cial products have been developed from this
collaboration and it has yielded important experi-
ences for the implementation of ABS.
5. Aveda Corporation, Mount Romance, and a range of
community groups in Western Australia: Partnership
based on sandalwood for personal care and cosmetic
company; benefit-sharing through the supply of raw
materials and agreements for the use in marketing of
indigenous peoples’ images and cultural property.
6. Natura and a range of community groups in Brazil:
Sourcing of certified raw materials for the personal
care and cosmetic sector; includes an agreement for
commercial use of traditional knowledge. This case
has affected Brazil’s developing ABS policy frame-
work.
7. Unilever, the British phytomedicine company Phy-
topharm, and the South African Council for Scien-
tific and Industrial Research: Involves the succulent
plant Hoodia, an appetite suppressant and a number
of ABS agreements between the multinational con-
sumer company, commercial Hoodia growers, and
the indigenous San people of southern Africa.
A unifying principle from each case study is the
value of building PPPs based on both trust and contract.
As eloquently elucidated by Lesser and Krattiger (2007,
p. 873), “considerable trust in the integrity of the con-
tracting company would seem to be critical, but …
checks should be included in the agreement.” In other
words, trust is the foundation for the sustainable system,
which albeit including contracts and agreements, recog-
nizes that no agreement can be structured to “permit
verification of every aspect,” i.e., cannot replace trust
(Lesser, 1998, p. 182). This central maxim is reaffirmed
by Laird and Wynberg (2008, pp. 29-30),
“A large element of trust and mutual
respect—by-products of partnerships to a far
greater extent than agreements solely for the sup-
ply of samples—is necessary to make these
agreements work in practice. … Material that
gets utilized in a ‘closed loop’ [e.g., a PPP
arrangement] faces fewer … problems. For
example, the licensing agreements to commer-
cialize Hoodia have well-defined tracking mecha-
nisms and all contracting parties have a
responsibility to ensure material is used only for
the purpose stipulated.”
Hence, whether the GR is plants, algae, fungi, or botani-
cals, the principles appear to broadly apply and should be
applicable to animal GRs such as horse populations of E/
SE Asia. Key elements include trust, tracking, PPPs, and
the capacity to engage in IP management, technology
transfer, and related ABS activities. In short, what is
needed are CNAs that are focal points for management
of horse GRs, promoting “communication and collabora-
tion, rather than suspicion and frustration” (Laird & Wyn-
berg, 2008, p. 37).
Conclusion
In developing countries, building human-resource and
institutional capacity that will enable active involvement
in a systematic value chain—from horse to proprietary
information which then flows back to the horse popula-
tions—will require a sequence of proprietary rights
agreements governed and regulated by both tangible and
intangible property regimes. A sequence of rights might
include the horse as a tangible chattel, a blood sample,
blood cells and DNA therein as tangible properties
(transferred via MTAs), the genetic code as proprietary
business information (protected as a trade secret), and/or
the application of this information for “an innovative or
creative and useful purpose”, i.e., a patented invention
(Lawson, 2006, p. 152). The value chain can be concep-
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tualized as a sustainable cycle, with an equitable distri-
bution of value at all stages (Figure 2).
Hence, establishment of CNAs in developing coun-
tries that proactively manage horse GRs can simultane-
ously actualize this proprietary value chain, enable
conservation, and drive commercialization, thus permit-
ting horses to continue to roam free while the genetic
information encoded in their cells is afforded protection
as a property right that can be licensed and built into
innovations for the benefit of all involved (Clements et
al., 2010; Coase, 1960). The dilemma of market failure
can be transformed into a dynamic system that con-
serves the indigenous horse populations of E/SE Asia
based on the potential market value of the genetic infor-
mation they embody. Conservation and innovation can
thereby become mutually reinforcing factors.
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